互聯(lián)網(wǎng)上一個(gè)新的網(wǎng)址(www.crphealth.com)被設(shè)計(jì)用于作為醫(yī)學(xué)專業(yè)人員與他們患者的C反應(yīng)蛋白數(shù)據(jù)的最新更新。

這個(gè)網(wǎng)址每日升級(jí)，內(nèi)容包括使用高密度C反應(yīng)蛋白做為心血管疾病與中風(fēng)的預(yù)后指標(biāo)，以及做為觀察性研究與臨床試驗(yàn)的結(jié)果。評(píng)審內(nèi)容的專家委員會(huì)包括Paul Ridker醫(yī)生(哈佛波士頓醫(yī)學(xué)院醫(yī)學(xué)教授，MA, USA)、Nader Rifai醫(yī)生(哈佛醫(yī)學(xué)院副教授)和Wolfgang Koenig醫(yī)生(德國烏爾姆大學(xué)醫(yī)學(xué)中心的醫(yī)學(xué)/心血管科教授)。該網(wǎng)址的贊助者之一是美國Dade Behring公司(Deerfield, IL, USA)。

該網(wǎng)址的內(nèi)容包括專家對(duì)炎癥與心臟疾病的交互式論壇、多媒體展示、病例研究、討論論壇、自我評(píng)估、幻燈和錄像圖書館、治療大綱、參考文獻(xiàn)、調(diào)查、以及最新的有關(guān)C反應(yīng)蛋白的醫(yī)學(xué)論文以及經(jīng)常被問及的問題。

Dade Behring公司主席、總裁兼首席執(zhí)行官Jim Reid-Anderson評(píng)論說：“這個(gè)新網(wǎng)址是我們公司堅(jiān)持不懈努力的一個(gè)明證：即為醫(yī)療保健提供者與患者提供信息以滿足他們的需要，從而獲得最佳質(zhì)量的健康保健”
 
New Website on C-Reactive Protein
 
A new website on the Internet (www.crphealth.com) is designed as a source for the latest updates on C-reactive protein (CRP) for medical professionals and their patients.

The website is updated daily and includes content on the use of high-density CRP (hsCRP) as a prognostic indicator of cardiovascular disease and stroke, as well as the results of observational studies and clinical trials. The editorial board of specialists reviewing the content includes Dr. Paul Ridker (professor of medicine, Harvard Medical School in Boston, MA, USA), Dr. Nader Rifai (associate professor, Harvard Medical School), and Dr. Wolfgang Koenig (professor of medicine/cardiology, University of Ulm Medical Center, in Germany). A sponsor of the website is Dade Behring (Deerfield, IL, USA).

The website’s content includes interactive forums, multimedia presentations by experts on inflammation and heart disease, case studies, discussion forums, self-assessments, slide and video libraries, treatment guidelines, references, polls, and the latest medical publications on CRP, as well as frequently asked questions.

“This new website exemplifies our company’s continuous efforts to make information available to healthcare providers and patients that meets their needs and enables the best quality of care,” remarked Jim Reid-Anderson, chairman, president, and CEO of Dade Behring.